Vanquish Oncology Inc. is an exciting new drug development company focused on targeting unexploited molecular defects in cancer cells to create first in class, personalized therapeutics for unmet or underserved cancer markets.
NEW: listing of PAC-1 Phase 1 trial on clinicaltrials.gov